Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01426425 · ClinicalTrials.gov registry record · Phase 3
Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia
A Phase 3 study, sponsored by Medtronic Cardiac Ablation Solutions.
- Completed
- Registry status
- Phase 3
- Development phase
- 572
- Enrollment target
NCT01426425 is a Phase 3 study that has completed, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 572 participants.
The verdict
NCT01426425, a Phase 3 study, has completed, sponsored by Medtronic Cardiac Ablation Solutions.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 572 participants
- Enrollment target
Study Summary
ICY-AVNRT (Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia) is a prospective multi-center, nonrandomized, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to demonstrate the safety and effectiveness of the Freezor® Xtra Cardiac CryoAblation Catheter for the cryoablation of the conducting tissues of the heart in the treatment of patients with atrioventricular nodal reentrant tachycardia (AVNRT) using an endocardial approach.
Interventions
- DEVICE Freezor Xtra Cryoablation Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 572 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01426425
The ClinicalTrials.gov registry entry for NCT01426425 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 572 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Ablation Solutions, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Freezor Xtra Cryoablation Catheter is the first listed.
NCT01426425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01426425 about?
NCT01426425 is a clinical study titled "Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia". ICY-AVNRT (Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia) is a prospective multi-center, nonrandomized, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to demonstrate the safety and effectiveness of the Freezor® Xt...
What is the current status of trial NCT01426425?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 572 participants. The study started on 2012-05. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01426425?
The interventions under investigation include: Freezor Xtra Cryoablation Catheter (DEVICE).
Who is sponsoring clinical trial NCT01426425?
This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.